Ayala Pharmaceuticals Inc (ADXS)

[mypekeispooped]

I consider any treatment that more than doubles OS time to be outstanding. "Canines vaccinated with ADXS31-164 had a median survival time of 956 days, and 56% were still alive three years after chemotherapy, compared to a historical control of 423 days and 22%, respectively [84]." This can't be spun in any other way other than to say it was a success. Yet, here we sit sub-dollar land. That is what boggles my mind. And, yes, there are some very sane people here.